Roundtable Federal Health Care Policy Priorities for Public Sector Purchasers

The Roundtable has a long-term commitment to maintaining programs that enable public workers, retirees, and their families to obtain high-quality health benefits at a cost that is affordable and sustainable for workers, their families, and their employers. It is our belief that national health care policies should advance innovative proposals to constrain costs, increase value, and improve quality and efficiency in the health care delivery system.

Our Priorities

  • Health Care Coverage and Cost Containment
  • Pharmaceutical Access, Costs, and Treatment
  • Provider Consolidation and Prices
  • Health Care Quality and Improved Outcomes
  • Mental and Behavioral Health
  • Innovation in Care Delivery

Roundtable Federal Action Agenda

The Roundtable advocates for its priorities in many ways – letters to Congressional and Administration leaders, testimony, press statements, and in meetings with Federal decision-makers. In addition, the Roundtable frequently joins its strategic partners advocating on behalf of issues of mutual interest.

Roundtable Advocacy and Outreach
  • June 29, 2023 – Letter to bipartisan Congressional Leadership regarding proposals to reform the Pharmacy Benefit Manager (PBM) industry [Letter]
  • April 18, 2023 – Press Release: Fighting Skyrocketing Hospital Prices, Leading Employer Groups Join Better Solutions for Healthcare to Launch National Campaign [Press Release]
  • March 6, 2023 – Roundtable Response to CMS-2023-0010; Advance Notice of Methodological Changes for Calendar Year (CY) 2024 for Medicare Advantage Capitation Rates and Part C and Part D Payment Policies [Letter]
  • February 16, 2023 – Testimony to U.S. Senate Committee on Commerce, Science and Transportation regarding the transparency and accountability of Pharmacy Benefit Managers (PBMs) [Testimony]
  • January 27, 2023 – Group letter supporting the Medicare Advantage program and the high-quality care it provides to over 29 million older adults and people with disabilities [Coalition Letter]
  • August 31, 2022 – Roundtable Response to CMS-4203-NC; Request for Information on Medicare Program – Medicare Advantage [Letter]
  • August 16, 2022 – Inflation Reduction Act – Roundtable Response [Press Release]
  • May 25, 2022 – Roundtable response to Federal Trade Commission request for comments on the Business Practices of Pharmacy Benefit Managers and Their Impact on Independent Pharmacies and Consumers [Letter]
  • April 10, 2022 – Letter to Biden Administration urging them to stand firm in the wake of attacks on the No Surprises Act that will harm consumers [Group Letter]
  • March 14, 2022 – Letter to Congressional Leadership re Drug Legislation [Letter]
  • December 6, 2021 – Letter to Democratic Congressional Leadership regarding unintended consequences that threaten to increase costs to Employer Group Waiver Plan (EGWP) retirees in Part D [Group Letter]
  • February 25, 2021 – Letter to Senate leadership regarding bipartisan legislative efforts to address the health and economic impact of the COVID-19 pandemic; including the need for more measures to protect public sector workers and their families as we recover from this crisis [Letter]

Key Congressional Contacts
Contacting Your Member of Congress